Hello Penny,
Link points to specifics to help enrollment at seven possible locations Genentech has made available for T-DM1 expanded access (EAP).
Expanded access is a process regulated by the Food and Drug Administration (FDA) that allows manufacturers to provide investigational new drugs to patients with serious diseases or conditions who cannot participate in a clinical trial.
http://www.clinicaltrials.gov/ct2/sh...dm1+eap&rank=1